DS
Deepti Singh
InGel Therapeutics Inc, Schepens Eye Research Institute of Massachusetts Eye and Ear, Dr MGR Educational and Research Institute, Yale University
0000-0003-3302-2110
Employment
-
InGel Therapeutics Inc CSO and Co-Founder2022 - Present
-
Schepens Eye Research Institute of Massachusetts Eye and Ear Research Fellow2018 - 2023
-
Yale University Associate Research Scientist2016 - 2018
-
Yale University Post-Doc Associate2015 - 2016
-
Yeungnam University Research Professor2013 - 2014
-
Yeungnam University Post-Doc Fellow2011 - 2013
Education
-
Dr MGR Educational and Research Institute Ph.D Biotechnology/Genetics2008 - 2011
Projects & Funding
Projects & funding information is unavailable.
Publications (67)
- Mechano-Chemical Effect of Gelatin- and HA-Based Hydrogels on Human Retinal Progenitor Cells Save
- Applications of artificial intelligence and deep learning in colorectal cancer surgery – Correspondence Save
- In vivo study to assess dosage of allogeneic pig retinal progenitor cells: Long-term survival, engraftment, differentiation and safety Save
- 3D printing cross-linkable calcium phosphate biocomposites for biocompatible surgical implantation Save
- Letter to the editor: Virtual reality in surgical training Save
- A bioinspired gelatin-hyaluronic acid-based hybrid interpenetrating network for the enhancement of retinal ganglion cells replacement therapy Save
- Controlling Growth Factor Diffusion by Modulating Water Content in Injectable Hydrogels Save
- Regulation and safety Save
- Unstimulated, Serum-free Cultures of Retinal Pigment Epithelium Excrete Large Mounds of Drusen-like Deposits Save
- Partially differentiated neuroretinal cells promote maturation of the retinal pigment epithelium Save